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AI In HeAltHcAre: 
etHIcs, cHAllenges, 
And ImplIcAtIons
From the Terminator to Iron Man’s JARVIS, the 
media has shaped our perception of artificial 
intelligence. The advent of artificial intelligence 
is felt through the daily use of virtual assistants 
like Apple’s Siri and Amazon’s Alexa. In addition, 
there has been an increase in concerns about the 
replacement of human jobs by robots and artifi-
cial intelligence as they become more advanced 
and capable of more complex tasks. Especially in 
medicine and healthcare, physicians have been 
apprehensive about this topic as computer-assist-
ed image analysis and deep learning continue to 
advance.
The potential applications of AI in medicine have 
given rise to ethical challenges because of its ca-
pacity to threaten patient preference, safety, and 
privacy [17]. Current policies and ethical guide-
lines for AI technology in healthcare are falling 
behind the progress made. The most pressing 
concerns address patient privacy and confidenti-
ality, the boundary between the roles of humans 
and AI, and future education of physicians con-
cerning changes in medicine. The lack of policy 
and guidelines also gives way to other limitations 
of implementing AI in hospitals. The lack of regu-
lation for disease-diagnosing algorithms involves 
liabilities in case of errors and malfunctions that 
raise ethical and privacy questions not addressed 
with regulations [19].
In one study, students were less likely to schedule 
diagnostic stress assessments when the provider 
was automated, even when the human provider 
was equally accurate. The distrust of “automated” 
providers, or medical AI, comes from a concern 
called uniqueness neglect. Consumers believe 
that machines can only operate in a standardized 
way that makes them incapable of making accu-
rate medical decisions because they are unique. 
In the same study, by contrast, participants were 
more likely to use a medical service when medi-
cal AI supported a human provider who made de-
cisions [11]. This further strengthens the value of 
using AI in healthcare.
People think that computer vision and interpret-
ing medical images through algorithms can re-
place doctors that rely on images to diagnose and 
treat patients. Research has shown that a doctor’s 
bedside manner can affect healthcare outcomes 
[12]. Even a patient’s relationship with their doc-
tors and their expectations about healing, which 
develops from their relationship, have shown 
that social context can drive placebo responses 
[23]. Soft skills like interacting with patients and 
bedside manners are irreplaceable and even have 
positive effects on patients.
The data-intensive scientific era has made it ad-
vantageous for physicians to become familiar 
with AI analytics. Especially within the medical 
field, medical AI users should be more aware that 
the input data quality limitations have health im-
plications because they affect the model accuracy 
for predicting clinical disease risks and patient 
outcomes [12]. Because these deep learning al-
gorithms rely on large amounts of high-quality 
medical data, patients with rare diseases cannot 
be treated in this way. This would also be the case 
of diseases that require expensive sophisticated, 
invasive, or dangerous tests [4].
There have been further talks about using AI as 
an empowerment tool for healthcare providers. 
Implementing AI in medicine and healthcare is 
inevitable. The promising future of AI in medi-
cine has not gone ignored. An Accenture report 
estimates that the AI health market will hit $6.6 
billion by 2021, which is a $6 billion increase from 
2014. As the industry grows, it will be difficult for 
healthcare providers to avoid the use of AI. It will 
be providers that utilize AI who will replace those 
who do not. 
For example, Stanford-Google digital-scribe pilot 
research aims to use AI-assisted voice recogni-
tion to enter data into a patient’s electronic health 
record systems while simultaneously patients are 
in the room [2]. This technology aims to reduce 
the time physicians spend manually entering 
data, which has shown to take up one-sixth of an 
average physician’s working hours [31]. In fact, a 
Mayo Clinic study has linked EHRs with physician 
burnout [22]. Physicians that utilize this technol-
ogy will replace ones that do not; they can take 
advantage of this technology to better support 
patients.
The hype about AI has given rise to concerns that 
have yet to be addressed for further implemen-
tation. As more research and advancements are 
made, what can we say about the future of AI in 
medicine in the next 10 years?
JuWon Park
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Possible 
Treatments of 
Respiratory Dis-
eases in Infants
Erin Yoo
Respiratory distress syndrome (RDS) is a respiratory disorder 
which frequently appears in preterm babies, especially those 
born six or more weeks early. This condition appears when 
low levels of surfactant are present in premature lungs (some 
full-term babies may also get RDS because of genetic factors 
that affect the production of surfactant) [34]. Surfactant is a 
compound in the lungs that prevents them from collapsing. 
They are specifically located in tissues around the alveoli to 
prevent the alveoli from sticking to one another. If the alve-
oli in the lungs were to stick together, it would block oxygen 
from entering the baby, which can lead to other complica-
tions. Symptoms of RDS can include breathing problems such 
as quick, shallow breathing, chest sharply pulling inwards 
during inhalation, grunting, nostrils flaring, and apnea (paus-
es between breaths that lasts for a few seconds). Infants diag-
nosed with RDS are moved to the neonatal intensive care unit 
(NICU) of a hospital [34].
Though most infants with RDS survive, they require extra 
medical care and treatment. Three main treatments are used 
to counter RDS: surfactant replacement therapy; breathing 
support; and oxygen therapy. Each therapy has its own ben-
efits and drawbacks. In surfactant replacement therapy, sur-
factant is supplied to the baby through a tube that is attached 
to a ventilator or an NCPAP (nasal continuous positive airway 
pressure machine) to provide breathing support. NCPAPs 
have recently become more popular than ventilators because 
of their gentle push of air through the nostrils. This is used 
until the baby can produce sufficient levels of surfactant on its 
own. The breathing support method uses the breathing ma-
chines mentioned above (ventilators and NCPAPs). Because 
RDS can cause other disorders such as a lung hemorrhage, 
blindness, and other eye problems, treatment can also entail 
treating related conditions [35]. Although these treatments can 
be life-saving, they can also cause more respiratory damage 
such as chronic breathing problems, asthma, brain damage, 
and bronchopulmonary dysplasia (BPD results when preterm 
infants with RDS are still suffering from it by their original 
due date). There is no long-term protection from BPD current-
ly. Thus a safer treatment for respiratory disorders would be 
extremely useful and valuable for premature infants.
One such potential treatment is curcumin. Curcumin is a sub-
stance found in turmeric, a spice. Turmeric is largely used in 
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Indian cooking such as curry, and also in many 
Asian cultures as a medicine. Studies and mod-
ern research show how curcumin could be 
used to help prevent and treat BPD, other re-
spiratory disorders, and even cancer. Accord-
ing to research by the Department of Biology 
from Texas Southern University, curcumin has 
been shown to suppress the development and 
spread of tumors through experiments con-
ducted on rodents [24]. In addition, research 
conducted by the Institute of Biosciences and 
Technology show that curcumin can prevent 
airways from swelling, or inflaming, (as in 
BPD) in mice [13]. Similarly, an experiment 
done by the American Journal of Physiology 
concluded that curcumin could protect devel-
oping lungs from bronchopulmonary dyspla-
sia (BPD) [18].
Fibroblasts, specifically lipofibroblasts, which 
can differentiate into myofibroblasts, are cells 
in connective tissue that are located in the 
lungs. Lipofibroblasts take part in preventing 
inflammatory injuries in the lungs, whereas 
myofibroblasts are commonly found in tis-
sue with chronic lung diseases, like BPD. This 
transformation from “lipo” to “myo” is caused 
by the peroxisome proliferator-activated re-
ceptor gamma molecules (PPAR-γ) [18]. Cur-
cumin has been found to affect those gamma 
molecules by blocking the transformation of 
“lipo” to “myo”, showing curcumin’s potential 
to reduce and prevent swelling in the lungs 
[18]. This experiment was done by treating 
mice with curcumin via injections and com-
paring the results to mice who were not inject-
ed. Experimental mice were placed in contain-
ers with more concentrated oxygen for 5 days 
to simulate hyperoxia, while control mice were 
kept in containers in regular conditions. It was 
discovered that curcumin prevented a de-
crease in alveoli numbers, increase in alveoli 
thickness (thinner alveoli makes gas exchange 
and breathing easier), and inflammation of 
the airways [18]. All these studies and research 
show that curcumin could be a very valuable 
tool in treating BPD, respiratory, and other in-
flammatory disorders.
Another food, grumichama berries or Brazil 
cherries, have been studied as a possible tool 
for therapeutic treatment in respiratory disor-
ders. Grumichama originates in Brazil, and is 
similar to a cherry (hence “Brazil cherries”); it’s 
just a little smaller. An experiment conducted 
by the Department of Biological Sciences from 
Lehman College and Graduate Center found 
that two main anthocyanins (delphinidin and 
cyanidin) in the berries were able to decrease 
levels of IL-8 production in cells treated with 
cigarette smoke extract [9]. Anthocyanins are 
pigments known to have antioxidant effects 
and are found in red, purple, and blue col-
ored foods like blueberries, raspberries, and 
grumichama. Moreover, chemokine interleu-
kin-8 (IL-8), is a cell that takes part in inflam-
mation during the immune response. IL-8 
proteins also cause the release of other in-
flammatory molecules to lung tissue, result-
ing in more damage to the lungs. Because the 
anthocyanins were able to lower the amount 
of IL-8 proteins in cells treated with cigarette 
smoke extract, grumixamas could be used in 
anti-inflammatory treatment for respiratory 
disorders as well. Consequently, infants liv-
ing in a household where cigarette smoke is 
prevalent, though not ideal, may soon have 
an option to treat their lungs from cigarette 
smoke.
So how could these possible treatments and 
preventions help our youngest and most an-
atomically different people—infants? Current 
treatments for common respiratory disorders 
among infants are not completely practical, 
as they can cause more damage to develop-
ing lungs. Thus, the other options reviewed 
above, curcumin and grumichama berries, 
may be a safer option for the young patients. 
Applications could include simple vaccine, 
pills, or other forms of oral medications. On 
the other hand, patients could use these foods 
as supplements, while also utilizing standard 
treatments. This could allow patients to use 
multiple treatment options while getting the 
same results as the more risky and traditional 
solutions.
In the end, it seems as if all the needed solu-
tions are already readily available to us, 
whether in man-made innovations like inhal-
ers and ventilators, or in nature like turmeric 
and berries. Because disorders like asthma 
and BPD are so diverse, it’s advantageous that 
there are many tools available. In the event 
that conventional treatments and medicines 
may not work or may not be accessible for a 
specific patient, it is valuable to keep up-to-
date with research on the respiratory system 
and new possible treatment methods. 
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Black Holes 
Suppress the 
Growth of Dwarf 
Galaxies
Black holes influence the formation of stars 
within galaxies [25]. Galaxies are clusters of 
stars held together by gravity, and the size of a 
galaxy is determined by the distribution of its 
stars. Dwarf galaxies are the most common type 
of galaxies in the universe, often orbiting larger 
galaxies and containing up to a few billion stars. 
For comparison, the Milky Way galaxy contains 
between 200-400 billion stars. In a recent recal-
culation of the mass of the Milky Way, scientists 
observed that black holes within the center of 
galaxies influence the way globular clusters 
around the galaxies form and travel around the 
center of the galaxy [20]. 
Black holes and dwarf planets allow scientists 
to study the evolution patterns of galaxies. Re-
searchers from the University of California, 
Riverside have used telescopes in Hawaii to 
observe winds around various black holes and 
have found that black holes create winds that 
hinder the formation and development of stars, 
thus preventing the growth of small galaxies. 
These winds were observed to be stronger than 
the researchers had initially anticipated, hav-
ing a drastic effect on the expansion of dwarf 
galaxies. The research done at the university 
focused on six dwarf galaxies, each with black 
holes that created gusts of wind moving at high 
velocities and containing ionized gas particles. 
These winds are created when particles in outer 
space come into contact with black holes. This 
contact generates high heat, due to friction and 
the strong gravitation of black holes. The heat 
causes massive amounts of energy to be gener-
ated to push gas particles out of the black hole. 
While wind produced by black holes can com-
press surrounding gas particles to form stars, 
the gas released from these black holes in dwarf 
galaxies does not compress surrounding parti-
cles because the gas itself comes from the black 
hole and is unable to form stars. Therefore, the 
presence and strength of the black holes within 
a galaxy are what determines the size of the gal-
axy by regulating the formation of stars. These 
discoveries may have further implications be-
yond the basic observation of star formations; 
they may potentially allow scientists to mea-
sure other properties of black holes and dif-
ferent-sized galaxies relative to their effects on 
each other [1].
pHyllIs sHen
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A supermassive black hole found at the center of a 
dwarf galaxy in 2014, as captured by the SINFONIA 
instrument from the European Southern Observato-
ry's Very Large Telescope in Chile [5]. This was the 
smallest galaxy in which this type of black hole was 
known to exist, which opened the possibility of find-
ing other supermassive black holes at the centers of 
other dwarf galaxies.
DARPA Funded 
Gene Modulation, 
the New Genetic 
Medicine?
ashlEY koca
The Defense Advanced Research Projects Agency, DARPA, 
is an organization out of the United States Department of De-
fense whose primary purpose is to progress the development 
of military technologies, first inspired and motivated by the So-
viet threat “Sputnik.” Within this agency resides a program, the 
PReemptive Expression of Protective Alleles and Response Ele-
ments (PREPARE), designed to counteract four major categories 
of human ailments: opioid overdose, organophosphate poison-
ing, exposure to gamma irradiation, and influenza infection [6]. 
PREPARE strives to design new methods of identification and 
development of medical countermeasures to promote genes 
that assist in protection against the ailments aforementioned—
but with one major rule: the medical countermeasures must af-
fect the genome without permanent alteration [7].
DARPA, most recently, has employed five teams to address in-
fluenza immunity and radiation protection within the gut. Each 
team strives to reach the end goal of producing at minimum one 
product to be reviewed by the U.S. Food and Drug Administra-
tion. Representing Columbia University, Dr. Harris Wang and 
members of the Wang lab comprise one team of DARPA’s PRE-
PARE initiative, pursuing a 9.5 million dollar study attempting 
to reduce the impact of radiation on the gut and blood through 
preventative therapy [28].
Although the focus on the blood and gut is seemingly oddly spe-
cific, the reasoning boils down to the fact that, in Homo Sapiens, 
the ionizing effects of radiation predominantly impact the stem 
cells housed in both those regions [21]. The risk of radiation im-
pacting the gut/bloodstream not only would impact soldiers, the 
main interest of DARPA, but would affect those using radiother-
apy as a cancer treatment option—thus expanding the benefits 
of this technology outside the realm of warfare.  
Current technologies attempting to combat the issue, unfortu-
nately, fall short. Common practices now work to regenerate 
blood cells, but only if delivered immediately after exposure to 
radiation. Prophylactic treatments have yet to be a reality, but, 
with the work of Dr. Wang and colleagues, they will hopefully 
soon become commonplace. 
The Wang lab plans to design a programmable gene modulator 
capable of oral introduction. Gene modulators are tools that al-
ter the expression of genes. These tools are designer molecules 
like triplex-forming molecules, synthetic polyamides, and zinc 
finger proteins [29]. Several mechanisms exist when utilizing 
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these different molecules. The triplex-forming 
molecules bind to the DNA helix and form a tri-
ple helical structure, allowing for a reduction 
in the gene’s transcription. Synthetic polyam-
ides inhibit transcription with sequence-specif-
ic minor groove DNA recognition. In that, they 
are a small collection of molecules that hydro-
gen bond to the minor groove of DNA through 
the specific recognition of base pairs.  Zinc-fin-
ger proteins bind instead to the major grooves 
of DNA. The modulation of zinc-finger proteins 
is more complicated, in that it can perform in a 
multitude of ways. In the case that the sequence 
the protein is targeting is an exon, transcription 
will be obscured. Another example of the range 
of zinc-finger motifs would be if the sequence is 
a methylase domain, in which case zinc-finger 
binding will only increase the methylation of the 
surrounding sequence. 
 The lab anticipates that the modulator will take 
hold in both the intestines and the liver. After 
which, the modulator should then induce the 
protection and regeneration of cells through reg-
ulating gene expression—which, in turn, chang-
es protein production. This then causes the liver 
cells to prompt the regeneration of red blood 
cells within the bone marrow. Risk of gastroin-
testinal injury due to radiation has been suggest-
ed by scientists to be linked to genotypic varia-
tions, hence the importance of gene modulation 
as a treatment option. 
equal potential for harm as well as good by 
these gene devices must be taken into consid-
eration when developing new tech. 
The support of organizations such as DARPA is 
crucial to the progression of science as it pro-
vides researchers with a plethora of financial 
opportunities and the support needed to con-
duct their science. Additionally, the interest of 
the Department of Defense is monumental in 
and of itself as it signifies the relevance of such 
research outside of the niche scientific com-
munity—the research has valuable, real-world 
applications that transcend the borders of pure 
academia. The continued support of these 
agencies provides hope to the scientific com-
munity, the US’ need for the advancement of 
science has not faltered since the origins of 
DARPA—the Sputnik scare has yet to be forgot-
ten. 
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When contemplating systems of genetic alter-
ation, those in control must consider the eth-
ics and potential implications of their actions. 
The genetic manipulation of any organism risks 
complications that could permanently alter the 
environment or the entire population of the or-
ganism that the method of manipulation was de-
signed to affect. Although this modulator is not 
designed to change the genes themselves merely 
their expression, certain alterations or increases 
in frequencies of expression could spell doom 
for an organism. Alternatively described as an 
“extinction tool,” gene drives and other instru-
ments of gene alteration have been recognized 
for their potential benefits to society as well as 
their potential for extreme consequences. The 
The modulator should 
then induce the protec-
tion and regeneration 
of cells.
Biomarkers of Chronic Pain: 
Precision Measurement and 
Application
According to the CDC, 1 in 5 patients 
suffer from some type of chronic pain. 
Thus, chronic pain is a condition many 
patients combat on a daily basis, given 
that there is no general cure for the pain 
[26]. While there are coping options 
that patients can pursue in an attempt 
to alleviate the pain, it will never fully 
go away. Hence, researchers are now 
attempting to understand how chronic 
pain affects the human body at a cellu-
lar level in order to eventually create a 
lasting solution.
This is done by identifying biomark-
ers in various biological features such 
as, most recently, in blood. The iden-
tification of common biomarkers was 
completed through a stepwise discov-
ery process: prioritization, validation, 
and testing. In the prioritization stage, 
a powerful longitudinal design within 
patients suffering from various psy-
chological disorders was utilized to 
prioritize candidate biomarkers and 
characterize the relationship between 
perceived and biological pain. Next, 
the top biomarkers were validated in 
patients actually diagnosed with pain 
disorders in an independent subject 
cohort. Following various clinical test-
ing, the biological pathways of each 
biomarker were identified along with 
correlations with existing drugs. From 
this, it was found that “GNG7, CNTN1, 
LY9, CCDC144B, and GBP1” [15] were 
the main biomarkers involved with 
hitEshi PatEl
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pain. Furthermore, these biomarkers can 
now be used as key components of assays 
in pain drug discovery. 
As one of the main groups who suffer 
from chronic pain is cancer patients, re-
searchers are focusing on the biomarkers 
specific to cancer patients as pain indi-
cators.  Since many cancers are based 
on genetic variants, genetic biomarkers 
were the focus of a study that explored 
pain pathways in cancer patients. This 
study found that single nucleotide poly-
morphisms (SNPs) are a common stable 
biomarkers in pain risk. As they change 
the genetic sequence of a gene’s protein, 
they are also likely to interact with can-
cers and affect their pain levels. 
Hence, this opens a future for 
further investigation and poten-
tial drug development. 
In an attempt to utilize this in-
formation for good, a company 
based in Indianapolis called 
MindX Sciences strives to quan-
tify pain levels through digital 
qualitative patient interviews 
and blood tests [26]. This is es-
pecially important since it is 
difficult for physicians to ana-
lyze pain levels in patients who 
suffer from diseases that pre-
vent them from accurately con-
veying their pain. This company will use 
the research of indicators and hopefully 
apply it to accurately gauge pain levels. 
Overall, pain research is one of the main 
focuses for bioresearchers today, given 
the difficulty physicians have in measur-
ing it. It is extremely likely more advances 
in pain research will be seen in the future. 
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This opens 
a future for 
further in-
vestigation 
and poten-
tial drug 
development.
How 
Regenerative 
Medicine is 
Leading to 
Discoveries
Regenerative medicine is a promising field 
working to restore the structure and func-
tion of damaged tissues and organs. Addi-
tional ly, regenerative medicine is working 
on finding solutions for permanently dam-
aged tissues. Researchers are now discov-
ering that cartilage in human joints could 
perhaps repair itself in a manner similar 
to animals such as axolotl, zebrafish, and 
bichir also exhibit. This possibility of car-
tilage regeneration could lead to a possible 
cure in arthritis, which is an inflammation 
of the joints [30]. The study’s focus was car-
tilage regeneration in the hip, knee, and an-
kle regions [10].
Young proteins play an important role in the 
recovery and repair of tissues in the mus-
cles, skin, organs, blood, hair, and nails. In 
the study, they found that young proteins 
help cartilage regeneration. They deter-
mined that the hip had the lowest amount 
of young proteins, while the knee had 
slightly more proteins than the hip, and the 
ankle had had the highest amount of young 
protein [10]. The researchers devised a way 
to determine the age of proteins to discover 
the mechanisms behind these findings.
osaYEnmWEn omozusi
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Professor Kraus, a professor at Duke 
University, and colleagues found the 
age of proteins using internal molec-
ular clocks integral to amino acids, 
which convert one form to another 
with predictable regularity. They dis-
covered that newly created proteins in 
tissue have few or no amino acid con-
versions, but as proteins become older, 
they have many amino acid conver-
sions [14]. Similarly, the age of cartilage 
largely depended on where it resided in 
the body. Cartilage in ankles is young, 
while it is middle-aged in the knee and 
old in the hips. The younger the pro-
teins are, the more efficient they are at 
healing [30].
Scientists also discovered that microR-
NA regulates the process of how long 
an area will heal. MicroRNAs are more 
active in animals that are known for 
limb, fin or tail repair, including sala-
manders, zebrafish, African freshwa-
ter fish and lizards. These microRNAs 
are also found in humans — an evolu-
tionary artifact that provides the capa-
bility in humans for joint tissue repair 
[10]. As in animals, microRNA activity 
varies significantly by its location: it is 
highest in ankles compared to knees 
and hips and higher in the top layer of 
cartilage compared to deeper layers of 
cartilage. Scientists like Dr. Ming-Feng 
Hsueh who research arthritis, are call-
ing this the “inner salamander capac-
ity” because it displays how possible 
cartilage regulation can take place [14]. 
The study of microRNA will advance 
medicines that could prevent, slow 
or reverse arthritis. Kraus says she is 
“very hopeful” that the findings could 
lead to therapies. One day, they also 
might discover how to regenerate part 
or all of a human limb. Potentially, she 
suggests, microRNAs could be “Inject-
ed directly into a joint to boost repair 
to prevent osteoarthritis after a joint 
injury or even slow or reverse osteoar-
thritis once it has developed.”
Although we still have a long way to go 
to explain why humans cannot regen-
erate, this study provides compelling 
evidence that there are many similar-
ities between human and salamander 
limbs. As stated by Professor Kraus, “If 
we can figure out what regulators we 
are missing compared with salaman-
ders, we might even be able to add the 
missing components back and develop 
a way someday to regenerate part or all 
of an injured human limb.” This is only 
the beginning of regenerative medi-
cine [30]. In the future, it could be ap-
plied to other tissues, not just cartilage.
An evolutionary arti-
fact that provides the 
capability in humans 
for joint tissue repair.
Interview: On the 
New Rhetoric and 
Communication Course
What inspired you to start this class?
Mr. Dean: It was sort of as a joke. We were learning 
about intersession at the time, and we joked around 
that we could do something about zombies. People 
laughed a bit, but then Dr. Randall said we could 
do a lot with that. It could be humanities-orient-
ed, while also having a science base. This meant 
looking at the cross appeal, such as the metaphor 
of zombies, how diseases behave like zombies, and 
why do we tell stories with zombies in them. We 
were able to do this intersession, and the year after 
that we did another one about the story of a germ. 
After doing these intersessions, we were looking to 
do this in a more authentic experience. 
  
How did you get started on planning it?
Mr. Dean: We went into it thinking of just coming 
up with a class. We didn’t worry about the logistics 
of it, but we just wrote what we would want to do 
with it. Then, we threw it to the school and said 
‘This is our plan, how do we make it happen?’
Dr. Randall: We tried to plan it in a way where, if 
there’s interest, different science and humanities 
faculty could pop in. This year, our theme is ne-
glected tropical diseases and rare genetic diseases, 
because they’re related to my biology background. 
But, it could have any theme depending on who’s 
teaching.
What was your vision for the class?
Mr. Dean: We tried to think of information as a 
life cycle. Where does it start? Who creates knowl-
edge in science? How is it channeled? We’re very 
focused on professional communication channels 
such as how scientists communicate with each 
other, and then how that science gets communi-
cated to real participants in the world. We wanted 
to think about the different people who have buy-
ins into scientific information. So, our plan was to 
structure our class around different communica-
tion experiences that relate to a similar topic. Dr. 
Randall has a specific focus in science, she has her 
background. We wanted to keep it close to what 
we know. When we were designing it, we wanted 
to imagine the flexibility if it were a different set 
of teachers. So, if wasn’t Dr. Randall and me, stu-
dents could conceive the class in different ways. 
You could have a physics teacher step into the 
classroom and do something completely different. 
Part of the benefit of it now is that Dr. Randall has 
experience in the fields that we’re learning about. 
I have my own experiences in communication as 
well. With a literary background, I’ve also taken 
courses in Technology Communication and Visu-
al Rhetoric, so I’ve got some tools that I can bring 
to the classroom as well. I can imagine if you had 
different teachers, they’re going to have their own 
expertise and experience, too. 
Dr. Randall: We wanted to give students an oppor-
tunity to have a class that is as rigorous in science 
as it is english. We wanted to give them a chance to 
build a portfolio of work, and the best way to learn 
how to communicate is to practice doing it. Our 
goal was to allow students to have a personalized 
version of the project that we used to do in Biology 
Seminar (a former literature review class) — with-
in certain guidelines, you’re able to pick a topic 
and work with it throughout the semester.
From what you’ve seen so far, is there anything that 
you would have done differently?
Dean: We question if we can get more experimen-
caitlYn castillo intErviEWs mr. dEan, dr. randall, and studEnts
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Living and learning in a mathematics and science 
academy, we’re surrounded by a myriad of STEM. 
From the original theories introduced thousands of 
years ago to the new innovations that come to life 
each day, we’re constantly gathering new informa-
tion. As we ponder concepts and ideas, it’s inter-
esting to learn about how they are presented to us. 
Mr. Dean and Dr. Randall tackle this field through 
the new, senior-only english elective Rhetoric and 
Communication: Science. The following interview 
has been edited for clarity, but the content has 
been approved by Mr. Dean, Dr. Randall, and the 
students interviewed.
We tried to think 
of information as 
a life cycle.
tal with it. What if we put together a board game? 
Or did an assignment on interpretive dance? But, 
the problem with that, is that we first wanted to 
give ourselves a basis. Additionally, those are very 
hard ideas to evaluate. Thinking about what we’re 
getting out of it is very difficult. For example, how 
do we look back on an assignment and think ‘Yes, 
that was worth our time.’ But, I think there’s sci-
ence communication out there that’s not tradi-
tional. Like memes, there’s always other things 
out there. I would need a lot more research to re-
ally grasp the field. Ultimately, when we get a bet-
ter handle on it, I wouldn’t mind experimenting. 
That’s where I want the class to go. 
Dr. Randall: Just yesterday, we had a conversation 
about how much creativity we allow or having 
some other less formal opportunities to present. If 
we were to do it again, we might have an expand-
ed improv day, where we’d ask questions such as 
“If you were to do outreach to young people, could 
you design a lab?” Next year we hope to allow some 
time for more creative projects.
What do you hope students will gain from this class?
Mr. Dean: Real working experience. I want you 
guys to feel like you could walk into an interview 
and be able to discuss real experience in science 
communication. Also, that you feel that the work 
you do is valuable to your time. This class is less 
about us teaching you from on-high, and more 
about you taking the tools and skills that we learn, 
and applying them to real situations. Because, 
that’s what I think rhetoric is all about.
What are your biggest struggles with this class?
Mr. Dean: I’ve never co-taught before. With most 
of the classes that I teach, I would consider my-
self an expert in those topics. But, in this case, I 
would not consider myself an expert in science. 
For me, that’s exciting, but also scary. I have to re-
ally collaborate. Dr. Randall and I would meet al-
most weekly; we looked at work together, debated 
ideas, had disagreements, and negotiated them. 
We thought about what we could do together, and 
what we’re individually good at. So, as much as this 
is a learning experience for you guys, I’ve also pro-
fessionally benefitted from the class. We’re learn-
ing from each other. It’s forced me to grow and 
take risks, and I think that’s fun.
What are your favorite parts about this class?
Mr. Dean: Seeing what you guys have produced 
each time. The fact that we can get into that class-
room and just talk about something. Almost every-
body in that room is throwing out great ideas and 
addressing ideas that I haven’t thought of. It makes 
me think “This is what IMSA is.” Working with tal-
ented students that have input into their learning 
process. 
Dr. Randall: Seeing the work that students put to-
gether. I’ve been really impressed. This is what we 
we’re hoping for. Seeing students work hard to un-
derstand the science and put things together has 
been very rewarding and fun. Hopefully they’ve 
found it fun, too.
The structure of the class consists of students working 
in groups of 3-5 people putting together projects on a 
specific neglected tropical disease or rare genetic dis-
ease. Here are a couple of questions and answers from 
some seniors currently taking the class. The names of 
the students are redacted for privacy, but they have 
read over their responses to ensure that their opinion 
is true.
What were you expecting when you took this class?
Student 1: I was expecting pretty much what I got. 
There’s a lot more science than English which is 
fine by me since those have consistently been my 
best and worst subjects respectively.
Student 2: I’m not really sure if I’m gonna be hon-
est, I just knew that I wasn’t that good at scientific 
writing and the class focused it on that and I knew 
it wouldn’t be easy—given that both teachers are 
demanding and the class itself would be challeng-
ing—but it interested it me more than the other 
English courses.
What are your favorite parts about this class?
Student 1: I enjoy the collaborative nature of 
the class and how we always work with the same 
groups and have larger projects over longer peri-
ods of time instead of constant work.
Student 2: I feel like I learned more than I thought 
I would, and I pay more attention to scientific writ-
ing and notice details that I would’ve had before. I 
am more attentive to scientific writing now.
What are you least favorite parts about this class?
Student 1: I don’t like the high expectations that 
the teachers have of how quickly we can learn cer-
tain topics, especially those from presentations 
by other students. I think assessments should be 
more about what we learn about scientific commu-
nication and less about actual science.
Student 2: I think some of the assignments are un-
necessary and are just assignments created to pass 
time.
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mAtHemAtIcAl 
epIdemIology: pAst 
FIndIngs And Future 
possIbIlItIes
Have you ever wondered how and why diseases 
spread? Well, the answer to that is Mathematical 
Epidemiology! Mathematical Epidemiology is the 
mathematical modeling of diseases to determine 
the rate at which people become infected with 
diseases. The study of infectious disease data be-
gan with the work of John Graunt in his 1662 book 
“Natural and Political Observations made upon 
the Bills of Mortality,” which lists weekly records 
of numbers and causes of death in the London 
parishes. These records began in 1592 and were 
kept continuously since 1603 [3]. Graunt analyzed 
the different causes of death and created a method 
of estimating the risks of dying from different dis-
eases. This was the first approach used to analyze 
data to determine the various risks of the disease. 
Now, what I just talked about was the first study 
of infectious disease data, but the first model in 
mathematical epidemiology was the work of Dan-
iel Bernoulli on inoculation against smallpox. Va-
riolation was introduced as a method to produce 
immunity against smallpox, with the negligible, 
mostly, risk of possible death. There was debate 
held on whether variolation was actually benefi-
cial, and Bernoulli was told to lead the study to 
answer this controversial question. The approach 
Bernoulli used was to calculate the increase in 
life expectancy if smallpox were to be eliminat-
ed as one of the causes of death. This approach 
led to the publication of a complete exposition in 
1766. These findings discussed were from many 
years in the past, while one of the main findings 
in mathematical epidemiology was the Kermack 
and McKendrick model in 1927 [3]:
Here, x(t) is the number of people who are sus-
ceptible to the disease itself, y(t) is the number of 
infectious individuals, and z(t) is the number of 
recovered individuals.
There is a clear history of Mathematical Epide-
miology that has served as a progression for epi-
demiologists to be able to use. However, now the 
challenge for epidemiological modeling would 
be to determine which situations would allow for 
slower exponential growth. This is an important 
direction that epidemic modeling must take, and 
suggestions to work past this challenge include 
metapopulation models with spatial structures 
that discuss population dynamics, such as con-
tact rates, etc. Another direction that would be 
interesting for epidemic modeling to take would 
be researching contact rates decreasing in time 
because of behavioral changes within individuals 
in response to diseases entering the body. Con-
tact rates are extremely important to determine 
whether someone will become infected or not. 
These are just a few of the future implications of 
Epidemic modeling and, I hope that all of you are 
as excited as I am, to see what’s in stock for the 
future of this unsaturated topic that is Mathemat-
ical Epidemiology.
madhav ParthasarathY
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The ‘Quantum Zeno 
Effect,’ Explained
Greek philosopher Zeno of Elea once had an inter-
esting thought (as philosophers do): if an arrow in 
flight is examined at an instant in time, the arrow 
appears to be motionless. However, if the arrow is 
motionless at every instant in time, and time is en-
tirely composed of instants, then the idea of “mo-
tion” is complete bogus. This posed an interesting 
mathematical problem.
Thankfully, “motion” was later un-bogused with 
the power of calculus. An intuitive refutation of 
Zeno’s paradox was provided by Aristotle, who not-
ed that "time is not composed of indivisible nows 
any more than any other magnitude is composed 
of indivisibles.” That is, instantaneous moments in 
time do not exist because it is impossible to com-
plete a task (such as firing an arrow from one point 
to another) with infinite steps. Bertrand Russell 
further criticized Zeno’s model of motion, arguing 
that, while it is true that an arrow cannot be “in 
motion” at an infinitely small duration of time, all 
motion requires is for the arrow to be at a point at 
one time, another point at another time, and at the 
appropriate points during the intervening time. 
Zeno’s paradox may not be successful in disman-
tling the foundations of motion, but Zeno may 
have been pleased to know that his ideas helped 
to name an effect observed in the quantum realm. 
To preface this, it’s important to acknowledge that 
slapping the word “quantum” in front of a dis-
proved paradox doesn’t necessarily make it any 
more sensible, but the quantum Zeno effect—a 
feature of quantum systems with an idea similar 
to Zeno’s arrow paradox—is a very real and observ-
able phenomenon [16].  
To put the quantum Zeno effect into understand-
able (yet nowhere near accurate) terms, take a 
common example: waiting for something to load. 
Suppose Zeno wanted to watch a YouTube video, 
but it was taking a long time to load and he was 
growing impatient. Then an idea struck him: if he 
closed his eyes while waiting for the video to load, 
periodically opening them to check on the prog-
ress, he might make it seem to speed up! He does 
this, measuring the state of the video frequently. 
However, he finds that his video—which usually 
finishes loading after a short while—doesn’t load 
at all. In fact, everytime he glances at the load-
ing icon, it seems like nothing changed! That’s 
because, according to the quantum Zeno effect, 
nothing—or at least very little—did change. By 
measuring the system frequently enough at spe-
cific intervals, Zeno was able to arrest his video’s 
time evolution (that’s assuming that his video is ac-
tually a particle abiding to quantum laws), keeping 
the video at its initial conditions. Put into simple 
terms, the quantum Zeno effect describes how a 
quantum system can be “frozen” by measuring it 
frequently enough [8],[27]. 
A better metaphor to explain this phenomenon is 
Schrodinger’s cat. Schrodinger’s famous thought 
experiment hypothesized that a cat locked in a box 
with a 50% of dying (usually due to a radioactive 
atom) will be half-dead and half-alive, a victim of 
the duality of conditions that exist within quantum 
physics. What’s curious is that the quantum Zeno 
effect can actually ensure that the cat always lives. 
Assume the fate of the cat relies on a radioactive 
atom which has a 50% chance of decaying and trig-
gering the destruction of a poison vial. Plotting the 
probability that the survivability of the cat over an 
x-value of time, a negatively sloped graph arises. 
This—while tragic—is to be expected; a greater 
span of time leads to a higher probability that the 
atom has decayed, and thus, a lower survivability 
of the cat. However, if the atom is “observed” over 
the course of its decay, a more lively graph takes 
form [16]: 
The “bounces” in the graph correspond with the 
times at which the system is measured, while the 
dashed line depicts the survivability of the cat 
without measurements. 
Everytime the system is measured, and the atom 
alEx zhang
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If we look at it often enough, it freezes.
still hasn’t decayed (in other words, it’s still in its 
initial conditions), it’s as if nothing happened at 
all. As a result, the system “resets” in a sense, col-
lapsing the system back into its initial state, and 
the process begins again. So, Schrodinger’s cat 
lives on, and Zeno’s quantum YouTube video loads 
in an endless spiral. As strange as it may seem, 
the quantum Zeno effect has been experimentally 
proven in the real world. Researchers from Cor-
nell found ways to use the quantum Zeno effect 
to freeze the tunneling of atoms—a phenomenon 
that usually occurs when atoms are exposed to 
extremely cold temperatures [27]. Instead of “tun-
neling” place to place as a result of having nearly 
0 velocity, the atoms exhibited reduced tunneling 
when measured. 
Thankfully, the quantum Zeno effect isn’t only 
understood under the context of “magic.” The ac-
tive action of measuring—that is, in the Cornell 
researcher’s case, shining an imaging laser on 
atoms—served as an outside force, disrupting the 
sensitive balance of quantum systems. This caused 
the reduction of tunneling. Further, as the Cornell 
researchers discovered, when measurements by 
the imaging laser became brighter and/or more 
frequent, the tunneling was dramatically reduced. 
Paradoxically, the act of measuring itself can dis-
turb the system meant to be measured, however 
miniscule the effect may seem. 
It’s evident that the quantum Zeno effect isn’t yet 
readily applicable for everyday life. It may be a 
long time until this phenomenon, like many oth-
er quantum phenomena, is fully understood and 
ready to be taught in high school classrooms. Plus, 
“understanding” requires acknowledging that 
even today’s most advanced measurement instru-
ments are inherently inaccurate on the quantum 
level, allowing humans only a distorted view of 
the quantum world through the lens of explorers 
shining spotlights on shy particles suffering from 
stage-fright. Even so, it’s valuable to take a look at 
what really is reality and explore the stranger parts 
of it. After all, that’s what Zeno of Elea did when 
he took an aspect of reality—motion—and thought 
about it for a little while, even if his work is un-
founded today. Quantum physics is still a relatively 
new and unexplored realm of physics, and it’s up 
to the thinkers of today to un-bogus it. 
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